DiaGenic Raises $12.1M in Private Placement

The Norwegian molecular diagnostics firm will use the funds to support its new strategy focused on neuroscience-related tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.